TAVR in Bicuspid Has the Same Results in Surgery at Hospital Level

Courtesy of Dr. Carlos Fava.

Bicuspid aortic stenosis patients (bicuspid AS) represent a small group and have not been included in the larger transcatheter aortic valve replacement (TAVR) studies, since they present different morphology and asymmetric calcification, which might come along with more paravalvular leak and less accurate positioning.

El reemplazo transcatéter en válvulas bicúspides suma evidencia pero continúan los desafíos

Between 2012 and 2016, 475,315 patients undergoing TAVR or surgical aortic valve replacement (SAVR) were included in the National Inpatient Sample database. 31.895 of these patients presented bicuspid aortic stenosis and 1055 (10.4%) received TAVR; the rest received SAVR.

Those undergoing TAVR were older, more often were women, diabetic, hypertensive and more often presented cardiac failure, kidney function deterioration, stroke, peripheral vascular disease, and implantable cardioverter-defibrillator. Therefore, a propensity score match was carried out, leaving 975 patients in each group.


Read also: Revascularization in Spontaneous Coronary Artery Dissection Causing ST-Segment Elevation Myocardial Infarction


In-hospital mortality was 3.1% in both groups. In addition, there were no differences between the strategies as regards cardiorespiratory arrest, cardiogenic shock, kidney function deterioration, stroke and the need for ventricular assistance. However, TAVR was associated to lower acute myocardial infarction rate (1% vs. 3.1% p=0.002), bleeding (23.6% vs. 44.6% p<0.001), transfusion (7.2% vs. 27.2% p<0.001), vascular complications (0.5% vs. 2.6% p<0.001), in-hospital stay (4 days vs. 7 days p<0.01), lower need for discharge to nursing facility (14.4% vs. 17.9% p=0.04) and lower respiratory assistance.

On the other hand, TAVR was associated with higher complete heart block (14.9% vs. 6.2% p<0.001) and need for definite pacemaker (13.8 vs. 4.6% p<0.001).

On the other hand, there were no differences in TAVR between bicuspids and tricuspids.

Conclusion

The National Inpatient Sample database showed similar mortality in severe bicuspid aortic stenosis patients undergoing TAVR or SAVR. Besides, TAVR presented similar mortality vs. tricuspid valves. further research is needed to assess long term evolution of TAVR in bicuspid aortic stenosis.

Courtesy of Dr. Carlos Fava.

Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.

Reference: Ayman Elbadawi, et al. J Am Coll Cardiol Intv 2019;12:1811–22.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....